Roquefort Therapeutics (LSE:ROQ) ROE % Adjusted to Book Value : -19.02% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics ROE % Adjusted to Book Value?

Roquefort Therapeutics's ROE % for the quarter that ended in Dec. 2023 was -32.15%. Roquefort Therapeutics's PB Ratio for the quarter that ended in Dec. 2023 was 1.69. Roquefort Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -19.02%.

Roquefort Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Roquefort Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics ROE % Adjusted to Book Value Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-24.25

-16.25

Roquefort Therapeutics Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	-26.34	-38.88	-27.31	-16.94	-19.02

Competitive Comparison of Roquefort Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Roquefort Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roquefort Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's ROE % Adjusted to Book Value falls into.

Roquefort Therapeutics ROE % Adjusted to Book Value Calculation

Roquefort Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-27.47%	/	1.69
	=	-16.25%

Roquefort Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-32.15%	/	1.69
	=	-19.02%

Roquefort Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics (LSE:ROQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ROQAF:USA

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines